vs
CUMBERLAND PHARMACEUTICALS INC(CPIX)与FiscalNote Holdings, Inc.(NOTE)财务数据对比。点击上方公司名可切换其他公司
FiscalNote Holdings, Inc.的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.6倍($22.2M vs $13.7M),CUMBERLAND PHARMACEUTICALS INC同比增速更快(31.1% vs -24.7%),CUMBERLAND PHARMACEUTICALS INC自由现金流更多($3.0K vs $-1.9M),过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高(26.9% vs -16.8%)
坎伯兰制药是一家专科制药企业,专注于开发、生产和商业化品牌处方药物,核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域,主要运营市场为美国,为相关医护人员与患者提供服务。
FiscalNote Holdings, Inc.(常称FiscalNote)是一家上市的软件数据与传媒企业,总部位于美国华盛顿特区,2013年由三位创始人创立。核心业务为通过政府关系管理服务FiscalNote GRM提供软件工具、平台、数据服务与资讯,同时依托人工智能平台分析美国待审议法案相关内容。
CPIX vs NOTE — 直观对比
营收规模更大
NOTE
是对方的1.6倍
$13.7M
营收增速更快
CPIX
高出55.7%
-24.7%
自由现金流更多
CPIX
多$1.9M
$-1.9M
两年增速更快
CPIX
近两年复合增速
-16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.7M | $22.2M |
| 净利润 | $-1.4M | — |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | -83.7% |
| 净利率 | -10.3% | — |
| 营收同比 | 31.1% | -24.7% |
| 净利润同比 | 25.8% | — |
| 每股收益(稀释后) | $-0.09 | $-2.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CPIX
NOTE
| Q4 25 | $13.7M | $22.2M | ||
| Q3 25 | $8.3M | $22.4M | ||
| Q2 25 | $10.8M | $23.3M | ||
| Q1 25 | $11.7M | $27.5M | ||
| Q4 24 | $10.4M | $29.5M | ||
| Q3 24 | $9.1M | $29.4M | ||
| Q2 24 | $9.8M | $29.2M | ||
| Q1 24 | $8.5M | $32.1M |
净利润
CPIX
NOTE
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $-1.9M | $-24.9M | ||
| Q2 25 | $-740.7K | $-13.3M | ||
| Q1 25 | $1.3M | $-4.3M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.5M | $-14.9M | ||
| Q2 24 | $-1.1M | $-12.8M | ||
| Q1 24 | $-1.9M | $50.6M |
毛利率
CPIX
NOTE
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率
CPIX
NOTE
| Q4 25 | -10.0% | -83.7% | ||
| Q3 25 | -23.7% | -43.4% | ||
| Q2 25 | -6.9% | -31.9% | ||
| Q1 25 | 11.0% | -50.0% | ||
| Q4 24 | -17.7% | -19.4% | ||
| Q3 24 | -18.6% | -23.1% | ||
| Q2 24 | -10.4% | -27.2% | ||
| Q1 24 | -22.0% | -35.6% |
净利率
CPIX
NOTE
| Q4 25 | -10.3% | — | ||
| Q3 25 | -23.4% | -110.8% | ||
| Q2 25 | -6.8% | -57.0% | ||
| Q1 25 | 10.7% | -15.4% | ||
| Q4 24 | -18.2% | — | ||
| Q3 24 | -17.0% | -50.7% | ||
| Q2 24 | -11.0% | -43.6% | ||
| Q1 24 | -22.9% | 157.6% |
每股收益(稀释后)
CPIX
NOTE
| Q4 25 | $-0.09 | $-2.81 | ||
| Q3 25 | $-0.13 | $-1.73 | ||
| Q2 25 | $-0.05 | $-0.08 | ||
| Q1 25 | $0.08 | $-0.03 | ||
| Q4 24 | $-0.13 | $1.88 | ||
| Q3 24 | $-0.11 | $-1.33 | ||
| Q2 24 | $-0.08 | $-0.09 | ||
| Q1 24 | $-0.14 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $26.3M |
| 总债务越低越好 | — | $128.4M |
| 股东权益账面价值 | $24.9M | $62.0M |
| 总资产 | $76.8M | $255.1M |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势,按日历期对齐
现金及短期投资
CPIX
NOTE
| Q4 25 | $11.4M | $26.3M | ||
| Q3 25 | $15.2M | $31.2M | ||
| Q2 25 | $16.1M | $38.5M | ||
| Q1 25 | $15.1M | $46.3M | ||
| Q4 24 | $18.0M | $34.6M | ||
| Q3 24 | $17.5M | $32.7M | ||
| Q2 24 | $17.3M | $37.7M | ||
| Q1 24 | $18.5M | $43.6M |
总债务
CPIX
NOTE
| Q4 25 | — | $128.4M | ||
| Q3 25 | — | $131.5M | ||
| Q2 25 | — | $116.7M | ||
| Q1 25 | — | $118.0M | ||
| Q4 24 | — | $147.1M | ||
| Q3 24 | — | $152.2M | ||
| Q2 24 | — | $145.9M | ||
| Q1 24 | — | $153.0M |
股东权益
CPIX
NOTE
| Q4 25 | $24.9M | $62.0M | ||
| Q3 25 | $26.1M | $75.5M | ||
| Q2 25 | $28.0M | $95.1M | ||
| Q1 25 | $28.7M | $98.7M | ||
| Q4 24 | $22.9M | $97.8M | ||
| Q3 24 | $24.8M | $98.5M | ||
| Q2 24 | $26.3M | $106.9M | ||
| Q1 24 | $27.5M | $106.1M |
总资产
CPIX
NOTE
| Q4 25 | $76.8M | $255.1M | ||
| Q3 25 | $65.9M | $273.9M | ||
| Q2 25 | $67.9M | $288.3M | ||
| Q1 25 | $69.9M | $299.7M | ||
| Q4 24 | $75.6M | $326.2M | ||
| Q3 24 | $76.7M | $337.9M | ||
| Q2 24 | $78.5M | $346.3M | ||
| Q1 24 | $81.5M | $357.8M |
负债/权益比
CPIX
NOTE
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.50× | ||
| Q3 24 | — | 1.54× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-279.0K |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $-1.9M |
| 自由现金流率自由现金流/营收 | 0.0% | -8.7% |
| 资本支出强度资本支出/营收 | 0.0% | 7.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $-18.6M |
8季度趋势,按日历期对齐
经营现金流
CPIX
NOTE
| Q4 25 | $3.0K | $-279.0K | ||
| Q3 25 | $187.2K | $-8.3M | ||
| Q2 25 | $843.8K | $-6.2M | ||
| Q1 25 | $3.9M | $3.3M | ||
| Q4 24 | $1.9M | $-1.3M | ||
| Q3 24 | $475.5K | $-3.0M | ||
| Q2 24 | $-855.7K | $-3.7M | ||
| Q1 24 | $-2.1M | $2.7M |
自由现金流
CPIX
NOTE
| Q4 25 | $3.0K | $-1.9M | ||
| Q3 25 | $163.4K | $-10.4M | ||
| Q2 25 | $817.3K | $-7.7M | ||
| Q1 25 | $3.9M | $1.3M | ||
| Q4 24 | $1.9M | $-3.4M | ||
| Q3 24 | $460.1K | $-5.4M | ||
| Q2 24 | $-862.8K | $-6.5M | ||
| Q1 24 | $-2.2M | $1.0M |
自由现金流率
CPIX
NOTE
| Q4 25 | 0.0% | -8.7% | ||
| Q3 25 | 2.0% | -46.2% | ||
| Q2 25 | 7.5% | -33.0% | ||
| Q1 25 | 32.9% | 4.7% | ||
| Q4 24 | 18.2% | -11.4% | ||
| Q3 24 | 5.1% | -18.4% | ||
| Q2 24 | -8.8% | -22.1% | ||
| Q1 24 | -25.6% | 3.3% |
资本支出强度
CPIX
NOTE
| Q4 25 | 0.0% | 7.4% | ||
| Q3 25 | 0.3% | 9.3% | ||
| Q2 25 | 0.2% | 6.4% | ||
| Q1 25 | 0.4% | 7.2% | ||
| Q4 24 | 0.0% | 6.8% | ||
| Q3 24 | 0.2% | 8.3% | ||
| Q2 24 | 0.1% | 9.4% | ||
| Q1 24 | 0.5% | 5.3% |
现金转化率
CPIX
NOTE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
NOTE
| Subscription | $21.2M | 95% |
| Advisory Advertising And Other | $1.0M | 5% |